Akèy › Glomeruloskleroz fokal segmantè › Georgia
Etid klinik pou Glomeruloskleroz fokal segmantè nan Georgia
6 etid pou Glomeruloskleroz fokal segmantè ap chèche patisipan nan sit nan Georgia.
Vil nan Georgia
Tèks ofisyèl etid la (Anglè)
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
- Emory Children's Center, Atlanta
- Coastal Medical Research, LLC, Brunswick
- Southeast Kidney Associates - East Point, East Point
- ak 1 plis
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07220083A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- Emory Children's Center- Site Number : 8400020, Atlanta
Ap rekriteFaz 2
Laj 16 a 75 · Tout sèks · Mizajou Sep 23, 2026 · NCT06500702A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site # 1, Lawrenceville
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 13, 2026 · NCT07268638NEPTUNE Match Study
- Emory University Hospital - Children's Hospital of Atlanta, Atlanta
Ap rekrite
Laj 1 a 80 · Tout sèks · Mizajou Jun 10, 2026 · NCT04571658Nephrotic Syndrome Study Network
- Emory University and Children's Healthcare of Atlanta, Atlanta
Ap rekriteEtid obsèvasyon
Jiska laj 80 · Tout sèks · Mizajou Jun 10, 2026 · NCT01209000A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
- Emory University School of Medicine, Atlanta
Ap rekriteFaz 3
Laj 12 a 80 · Tout sèks · Mizajou Feb 3, 2026 · NCT05183646Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.